orphenadrine and levodopa
orphenadrine has been researched along with levodopa in 9 studies
Research
Studies (9)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (55.56) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Postma, JU; Van Tilburg, W | 1 |
Marsden, CD | 1 |
Parkenberg, H | 1 |
Albani, F; Baruzzi, A; Contin, M; Martinelli, P; Procaccianti, G; Riva, R | 1 |
Albizzati, MG; Bassi, S; Calloni, E; Frattola, L; Sbacchi, M | 1 |
van der Drift, JH | 1 |
Bianchi, AM; Foffani, G; Locatelli, M; Moxon, KA; Pellegrini, M; Pesenti, A; Priori, A; Tamma, F; Villani, RM | 1 |
Reviews
1 review(s) available for orphenadrine and levodopa
Article | Year |
---|---|
Advances in the management of parkinson's disease.
Topics: Amantadine; Anesthesia; Humans; Levodopa; Orphenadrine; Parasympatholytics; Parkinson Disease; Social Adjustment; Trihexyphenidyl | 1976 |
Other Studies
8 other study(ies) available for orphenadrine and levodopa
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
Topics: Aged; Amantadine; Benztropine; Biperiden; Delirium; Drug Eruptions; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease | 1975 |
[Treatment of parkinsonism].
Topics: Amantadine; Benztropine; Biperiden; Humans; Levodopa; Orphenadrine; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1976 |
Combined levodopa-anticholinergic therapy in the treatment of Parkinson's disease. Effect on levodopa bioavailability.
Topics: Adult; Aged; Biological Availability; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease; Statistics as Topic | 1991 |
Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopa.
Topics: Aged; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease | 1986 |
Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study.
Topics: Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease | 1987 |
Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.
Topics: Action Potentials; Adult; Aged; Alpha Rhythm; Antiparkinson Agents; Apomorphine; Beta Rhythm; Biological Clocks; Dose-Response Relationship, Drug; Electric Stimulation Therapy; Electrodes, Implanted; Humans; Levodopa; Middle Aged; Neurons; Orphenadrine; Parkinson Disease; Periodicity; Subthalamic Nucleus | 2004 |